Disclaimer: I am not an investment advisor and this is not investment advice. Please do your own research and consult your investment advisor.

Grab your pick and shovel, there’s gold in them thar hills! Or should I say… green. And like the days of the Australian gold rush, some of these names will go on to make their fortune, while others will limp home, carrying a worn-down pick and a wheelbarrow full of iron sulfide and quartz.

Cannabis investment is experiencing a period of rapid growth as Australian companies join the rush to create the next successful product. The future is uncertain, but regulations are changing rapidly, spurred on by recent events in the US, making Australia an attractive location to grow, process and sell cannabis products.

So grab a pick and let’s get digging. Here are the Australian cannabis and cannabis-related companies listed on the ASX:

Auscann
ASX: AC8
Auscann is involved in research and development, including the creation of a hard shell capsule for optimal cannabis delivery.

Althea Group
ASX: AGH
Althea Group supplies medicinal cannabis for a variety of health conditions.

Australian Primary Hemp
ASX: APH
Established in 2016, Australian Primary Hemp is a 100% Australian owned grower of hemp and producer of hemp products.

Avecho Biotech
ASX: AVE
Avecho Biotech is a Melbourne-based biotechnology company developing pharmaceuticals for humans and animals, including the creation of a superior delivery system for cannabinoids.

BOD Australia
ASX: BDA
BOD Australia began in 2014, creating herbal productsand supporting the use of rigorous research and testing. The company entered the CBD sphere in 2016.

Botanix Pharmaceuticals
ASX: BOT
Botanix Pharmaceuticals are a synthetic cannabinoid company with a focus on dermatology and antimicrobial products.

Cann Group
ASX: CAN
Established in 2014, Cann Group was the first company to secure a cannabis cultivation licence, and aims to develop a range of medicinal cannabis and resin products.

Cann Global
ASX: CGB
Cann Global owns a unique cannabis seedbank and aims to research, grow and develop high quality cannabis and hemp products.

Cronos Australia
ASX: CAU
Cronos Australia provides patient access to medicinal cannabis, and the company aims to be a leading health and wellness company in the Asia Pacific region with a range of CBD and THC products.

Cannpal
ASX: CP1
Cannpal is involved in the creation of medicinal cannabis products for pets.
Update: Cannpal has now joined forces with Auscann.

Creso Pharma
ASX: CPH
Creso Pharma partners with international brands to deliver world class cannabis products to a global market.

ECS Botanics
ASX: ECS
Tasmanian-based ECS Botanics grow industrial hemp seeds, and have been approved for both medicinal cannabis manufacturing and medicinal cannabis cultivation licenses.

Emyria
ASX: EMD
Emyria are involved in data-backed innovations and research into drug development.

Engage BDR Limited
ASX: EN1
Engage BDR deals with digital advertising and offer custom curated inventory packages for cannabis companies.

Ecofibre
ASX: EOF
Ecofibre aims to be a global leader in sustainable hemp technologies.

Epsilon Healthcare (Formerly The Global Group)
ASX: EPN (Formerly THC)
Epsilon Healthcare (Formerly The Global Group) has the largest TGA licensed cannabis extraction and manufacturing facility in the southern hemisphere.

Esense Lab
ASX: ESE
Israel based Esense Lab focuses on research into medical and wellness terpene products.

Eve Investments
ASX: EVE
Eve Investments recently launched a line of hemp honey to the Chinese market.

Elixinol Global
ASX: EXL
Elixinol Global are involved in hemp derived CBD products, and operate in Australia, the Americas and Europe.

IDT Australia
ASX: IDT
Melbourne based IDT Australia is a manufacturing company specialising in high potency pharmaceutical ingredients.

Incannex Healthcare
ASX: IHL
Incannex Healthcare began as a mouthguard company, with recent successful medicinal cannabis trials expanding the scope of the company.

ALL AUSTRALIAN CANNABIS SHARES ON THE ASX


Little Green Pharma
ASX: LGP
Little Green Pharma was the first Australian medicinal cannabis company to produce locally grown medicines for Australian and overseas markets.

Lifespot Health
ASX: LSH
Lifespot health provides platforms for health professionals, including features such as medicine delivery and diagnostic tools.

Medlab Clinical
ASX: MDC
Medlab Clinical is an Australian biotechnology company specialising in nanotechnology-powered drug delivery for various health conditions.

MMJ
ASX: MMJ
MMJ is a cannabis investment company, with investments in Australia, Canada and Europe.

Murray River Organics
ASX: MRG
Murray River Organics is an Australian certified organic food producer and manufacturer.

MGC Pharmaceuticals
ASX: MXC
MGC Pharmaceuticals is a biopharma company focusing on plant derived medicines.

Palla Pharma
ASX: PAL
Palla Pharma is an Australian owned pharmaceutical company, with operations in Victoria, Tasmania and Norway.

Roto-Gro International
ASX: RGI
Roto-Gro International provides automated technological solutions for agriculture businesses, such as the patented rotational garden system.

Rhinomed
ASX: RNO
Rhinomed are involved in research and the creation of a range of products for snoring, respiratory issues and sleep aids.

Roots Sustainable
ASX: ROO
Since 2009, Israel based Roots Sustainable has been involved in sustainable agriculture technologies, including the creation of optimal cannabis growing techniques.

Stemcell United
ASX: SCU
Singapore based Stemcell United are involved in research and development for cannabis beauty products and also conduct various stem cell trials for the production of medicinal products.

Suda Pharmaceuticals
ASX: SUD
Suda Pharmaceuticals specialise in oral spray delivery of medications.

Wide Open Agriculture
ASX: WOA
Wide Open Agriculture is a farming company with plans to become a major hemp distributor.

YPB Group
ASX: YPB
YPB Group deals with brand protection technologies for e-commerce providers.

Zelira Therapeutics
ASX: ZLD
Zelira Therapeutics is involved in research studies, and has developed a range of cannabinoid medications for sale in the US and Australia.

Written by

Leave a Reply